Your search returned 1978 results.

Results
	541.	Lupin Peptides Modulate the Protein-Protein Interaction of PCSK9 with the Low Density Lipoprotein Receptor in HepG2 Cells. [electronic resource] by Lammi, Carmen Zanoni, Chiara Aiello, Gilda Arnoldi, Anna Grazioso, Giovanni Producer: 20180703 In: Scientific reports vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	542.	[Lipid-lowering drugs and PCSK9]. [electronic resource] by Millán Núñez-Cortés, Jesús Mostaza Prieto, José M Producer: 20170529 In: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis vol. 28 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	543.	Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering. [electronic resource] by Shapiro, Michael D Fazio, Sergio Producer: 20180829 In: Nature reviews. Cardiology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	544.	Heparan sulfate proteoglycans present PCSK9 to the LDL receptor. [electronic resource] by Gustafsen, Camilla Olsen, Ditte Vilstrup, Joachim Lund, Signe Reinhardt, Anika Wellner, Niels Larsen, Torben Andersen, Christian B F Weyer, Kathrin Li, Jin-Ping Seeberger, Peter H Thirup, Søren Madsen, Peder Glerup, Simon Producer: 20180208 In: Nature communications vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	545.	Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study. [electronic resource] by Xie, Wuxiang Liu, Jing Wang, Wei Wang, Miao Qi, Yue Zhao, Fan Sun, Jiayi Liu, Jun Li, Yan Zhao, Dong Producer: 20170807 In: International journal of cardiology vol. 215 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	546.	The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia. [electronic resource] by Tziomalos, Konstantinos Producer: 20180208 In: Current pharmaceutical design vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	547.	Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia. [electronic resource] by Papademetriou, Vasilios Stavropoulos, Konstantinos Papadopoulos, Christodoulos Koutsampasopoulos, Konstantinos Dimitriadis, Kiriakos Tsioufis, Kostas Producer: 20191121 In: Current pharmaceutical design vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	548.	Association between circulating proprotein convertase subtilisin/kexin type 9 levels and prognosis in patients with severe chronic kidney disease. [electronic resource] by Rasmussen, Laust Dupont Bøttcher, Morten Ivarsen, Per Jørgensen, Hanne Skou Nyegaard, Mette Buttenschøn, Henriette Gustafsen, Camilla Glerup, Simon Bøtker, Hans Erik Svensson, My Winther, Simon Producer: 20201026 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	549.	Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition. [electronic resource] by Brumpton, Ben M Fritsche, Lars G Zheng, Jie Nielsen, Jonas Bille Mannila, Maria Surakka, Ida Rasheed, Humaira Vie, Gunnhild Åberge Graham, Sarah E Gabrielsen, Maiken Elvestad Laugsand, Lars Erik Aukrust, Pål Vatten, Lars Johan Damås, Jan Kristian Ueland, Thor Janszky, Imre Zwart, John-Anker Van't Hooft, Ferdinand M Seidah, Nabil Georges Hveem, Kristian Willer, Cristen Smith, George Davey Åsvold, Bjørn Olav Producer: 20200312 In: Circulation. Genomic and precision medicine vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	550.	Plasma PCSK9 levels correlate with cholesterol in men but not in women. [electronic resource] by Mayne, Janice Raymond, Angela Chaplin, Anna Cousins, Marion Kaefer, Nadine Gyamera-Acheampong, Charles Seidah, Nabil G Mbikay, Majambu Chrétien, Michel Ooi, Teik Chye Producer: 20070928 In: Biochemical and biophysical research communications vol. 361 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	551.	MMP-2 inhibits PCSK9-induced degradation of the LDL receptor in Hepa1-c1c7 cells. [electronic resource] by Wang, Xiang Berry, Evan Hernandez-Anzaldo, Samuel Sun, Difei Adijiang, Ayinuer Li, Liang Zhang, Dawei Fernandez-Patron, Carlos Producer: 20150414 In: FEBS letters vol. 589 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	552.	PCSK9 antibodies for the treatment of hypercholesterolemia. [electronic resource] by Gouni-Berthold, Ioanna Berthold, Heiner K Producer: 20151105 In: Nutrients vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	553.	[PCSK9 monoclonal antibody inhibition: current evidence and future perspectives of lipid-lowering therapy according to the available results from the ODYSSEY program]. [electronic resource] by Lettino, Maddalena Producer: 20150611 In: Giornale italiano di cardiologia (2006) vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	554.	Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis. [electronic resource] by Tavori, Hagai Giunzioni, Ilaria Linton, MacRae F Fazio, Sergio Producer: 20140130 In: Circulation research vol. 113 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	555.	Turning the Titanic. [electronic resource] by Zerhouni, Elias A Producer: 20141024 In: Science translational medicine vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	556.	Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs. [electronic resource] by Abifadel, Marianne Elbitar, Sandy El Khoury, Petra Ghaleb, Youmna Chémaly, Mélody Moussalli, Marie-Line Rabès, Jean-Pierre Varret, Mathilde Boileau, Catherine Producer: 20150515 In: Current atherosclerosis reports vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	557.	Determining the binding affinity of therapeutic monoclonal antibodies towards their native unpurified antigens in human serum. [electronic resource] by Bee, Christine Abdiche, Yasmina N Pons, Jaume Rajpal, Arvind Producer: 20140620 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	558.	Cholesterol-lowering drugs: science and marketing. [electronic resource] by Garattini, Livio Padula, Anna Producer: 20171226 In: Journal of the Royal Society of Medicine vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	559.	[Monoclonal antibodies against PCSK9: from bench to clinic]. [electronic resource] by Guijarro Herraiz, Carlos Producer: 20170529 In: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis vol. 28 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	560.	Effect of long-term physical activity on PCSK9, high- and low-density lipoprotein cholesterol, and lipoprotein(a) levels: a prospective observational trial [electronic resource] by Sponder, Michael Campean, Ioana-Alexandra Dalos, Daniel Emich, Michael Fritzer-Szekeres, Monika Litschauer, Brigitte Bergler-Klein, Jutta Graf, Senta Strametz-Juranek, Jeanette Producer: 20190110 In: Polish archives of internal medicine vol. 127 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.